Zhongchao Inc

Análisis de la acción Zhongchao Inc (ZCMD)

$0.925

-0.043 (-4.68%)Al cierre

Loading chart…
High
0.980
Open
0.924
VWAP
0.93
Vol
1.19M
Mkt Cap
3.23M
Low
0.880
Amount
1.10M
EV/EBITDA, TTM
0.00

Zhongchao Inc is a holding company primarily engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public. The Company is primarily engaged in the provision of medical training and education services and assistance in patient-aid projects through MDMOOC online platform and offline formats. The MDMOOC online platform includes MDMOOC mobile application (App), MOOC Medical WeChat subscription account, and MDMOOC website. Under the MDMOOC brand, the Company provides various online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. The Company primarily operates its businesses in the domestic market.

AI analysis of Zhongchao Inc (ZCMD)

sell

Zhongchao Inc. (ZCMD) is not a good buy right now due to its extremely low current price of $0.92, a staggering year-to-date change of -99.74%, and a negative forward P/E ratio of 0, indicating no expected earnings growth. The recent share consolidation aimed at maintaining Nasdaq compliance has not instilled enough confidence, as evidenced by a 5-day change of -0.43% and a 20-day change of -18.19%. The main risk is the company's significant decline in stock value, which raises concerns about its long-term viability.

Métricas de valoración

The current forward P/E ratio for Zhongchao Inc (ZCMD) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Sobrevalorada
0.00
Infravalorada
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Sobrevalorada
0.00
Infravalorada
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Sobrevalorada
0.00
Infravalorada
0.00

Alphio AI Price Scenarios for ZCMD

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ZCMD

$1.32

Precio del escenario

B

Base

Base · 50%ZCMD

$1.17

Precio del escenario

B

Bear

Bear · 25%ZCMD

$1.00

Precio del escenario

Cronología de eventos

2026-07-23 (ET)

09:30:00

Zhongchao Enters Agreement to Issue 4.55 Million Shares at $1.10

2026-06-25 (ET)

08:31:00

Zhongchao to Effectuate 1-for-3 Share Consolidation

2026-05-07 (ET)

14:50:00

Zhongchao Plans Best-Efforts Offering of 5.56M Units

2026-02-26 (ET)

08:50:00

Zhongchao to Effectuate 1-for-8 Share Consolidation

Noticias

ZCMD FAQ — answered by Alphio AI

Zhongchao Inc is a holding company primarily engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public. The Company is primarily engaged in the provision of medical training and education services and assistance in patient-aid projects through MDMOOC online platform and offline formats. The MDMOOC online platform includes MDMOOC mobile application (App), MOOC Medical WeChat subscription account, and MDMOOC website. Under the MDMOOC brand, the Company provides various online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. The Company primarily operates its businesses in the domestic market. It operates in the Academic & Educational Services sector.

Zhongchao Inc. (ZCMD) is not a good buy right now due to its extremely low current price of $0.92, a staggering year-to-date change of -99.74%, and a negative forward P/E ratio of 0, indicating no expected earnings growth. The recent share consolidation aimed at maintaining Nasdaq compliance has not instilled enough confidence, as evidenced by a 5-day change of -0.43% and a 20-day change of -18.19%. The main risk is the company's significant decline in stock value, which raises concerns about its long-term viability.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis